Medical associations in the US say they are optimistic about the potential for CBD to treat patients, but have warned people to proceed with caution when treating themselves due to a lack of rigorous scientific studies ...
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.
